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 gene under control of the strong constitutive  TEF1  promoter 
or the inducible  AYNI1  promoter. The enzyme showed high 
substrate specificity for uric acid, a broad temperature and 
pH range, high thermostability and the ability to reduce uric 
acid content in food.  © 2013 S. Karger AG, Basel 
 Introduction 
 Hyperuricemia is defined as serum uric acid concen-
tration >6.8 mg/dl [Terkeltaub, 2010], a level that is above 
the physiological saturation of uric acid. Asymptomatic 
hyperuricemia can be detected in some cases and is caused 
by reduced renal uric acid excretion combined with in-
creased uric acid synthesis from endogenous sources 
(breakdown of purines during cell turnover) or exoge-
nous sources (food with high purine content) [Wolfram, 
1992]. A minority of patients with hyperuricemia develop 
symptoms of gout, tophi and acute uric acid nephropathy 
[Wortmann, 2002], which are caused by the formation
of micro- and macroscopic monosodium urate crystals. 
These crystals cause swelling, inflammation and pain in 
the joints of the lower extremities [Sorbera et al., 2010] 
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 Abstract 
 Hyperuricemia and its symptoms are becoming increasingly 
common worldwide. Elevated serum uric acid levels are 
caused by increased uric acid synthesis from food constitu-
ents and reduced renal excretion. Treatment in most cases 
involves reducing alcohol intake and consumption of meat 
and fish or treatment with pharmaceuticals. Another ap-
proach could be to reduce uric acid level in food, either dur-
ing production or consumption. This work reports the pro-
duction of recombinant urate oxidase by  Arxula adeninivo-
rans  and its application to reduce uric acid  in a food product. 
The  A. adeninivorans urate oxidase amino acid sequence was 
found to be similar to urate oxidases from other fungi (61–
65% identity). In media supplemented with adenine, hypo-
xanthine or uric acid, induction of the  urate oxidase (AUOX) 
 gene and intracellular accumulation of urate oxidase (Auoxp) 
was observed. The enzyme characteristics were analyzed 
from isolates of the wild-type strain  A. adeninivorans  LS3, as 
well as from those of transgenic strains expressing the  AUOX 
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and worldwide, between 1 and 2% of adults, mostly male, 
and often in industrialized countries, are affected by gout 
[Sorbera et al., 2010].
 In the recent times, different treatments for gout have 
been developed with three main goals – treatment of 
acute gout attacks, prophylaxis, and long-term therapies 
to lower uric acid levels [Dalbeth, 2011]. In the case of 
acute gout attacks, patients are often treated with non-
steroidal anti-inflammatory drugs and glucocorticoids 
for reduction of pain and treatment of inflammation 
[Sorbera et al., 2010] or recombinant urate oxidase-like 
rasburicase (Fasturtec ® ; Sanofi-Aventis) [Leinmüller, 
2001] or pegloticase (Krystexxa ® ; Savient Pharmaceuti-
cals) [Schlesinger et al., 2011] to rapidly reduce uric acid 
levels by converting it to allantoin which is 5–10 times 
more soluble. Common prophylaxis and long-term ther-
apies are made with the xanthine oxidase inhibitors allo-
purinol and febuxostat or uricosuric agents such as pro-
benecid or benzbromarone [Burns and Wortmann, 2011; 
Wittköpper et al., 2011].
 Prevention can be achieved through lowering the up-
take of exogenous uric acid by avoiding purine-rich food 
such as meat (especially muscle tissue, bowels and skin), 
certain fish (herring and shrimps) and plants (soy and 
other legumes), reducing alcohol and through weight loss 
[Wolfram, 1992]. Some of these restrictions can lead to 
reduction of life quality. Our novel approach for preven-
tion of hyperuricemia is through the reduction of uric 
acid content of food by urate oxidase treatment, either 
during food production or during ingestion.
 Urate oxidase (EC 1.7.3.3; urate oxygen oxidoreduc-
tase) catalyzes the oxidative opening of uric acid in the 
presence of oxygen. The reaction is an enzymatic oxida-
tion combined with a non-enzymatic hydrolysis step, 
which produces hydrogen peroxide [Kahn et al., 1997]. 
The product, allantoin, is 5–10 times more soluble than 
uric acid and does not precipitate at physiological con-
centrations. Urate oxidase can also be used to analytically 
to determine uric acid content of serum [Liu et al., 1994; 
Zhao et al., 2009] or therapeutically for uric acid reduc-
tion in biological fluids for resolving hyperuricemic dis-
orders such as tumor lysis syndrome, which can occur 
during chemotherapy [Wang et al., 2006].
 Urate oxidase is an inducible enzyme that is found in 
a variety of organisms such as bacteria [Arima and Nose, 
1968; Lotfy, 2008], fungi [Franke and Krieg, 1952], yeast 
[Liu et al., 1994], algae [Alamillo et al., 1991], plants 
[Montalbini et al., 1997] and is expressed in mammalian 
peroxisomes in specific tissues [Antonenkov and Pan-
chenko, 1978; Rajoka et al., 2006]. It is however absent in 
higher primates (hominoids and some New World mon-
keys), birds, terrestrial reptiles and most insects [Keebaugh 
and Thomas, 2010; Keilin, 1959; Oda et al., 2002]. The 
lack of functional urate oxidase in higher primates is a 
consequence of independent mutations in the coding se-
quence of the urate oxidase gene [Oda et al., 2002; Wu et 
al., 1992] and results in uric acid as the final purine deg-
radation product in these organisms.
 In this study we present the construction of an  Arxula 
adeninivorans strain that overexpresses  the urate oxidase 
 (AUOX) gene and produces high concentrations of urate 
oxidase, and its application for the reduction of uric acid 
in food. The  AUOX gene was isolated from the yeast  A. 
adeninivorans (syn.  Blastobotrys adeninivorans ) [Kurtz-
mann and Robnett, 2007], an arthroconidial, xerotol-
erant, anamorphic, non-pathogenic, non-conventional 
yeast [van der Walt et al., 1990], which has unusual bio-
chemical features.  A. adeninivorans is able to assimilate 
and utilize a broad range of substrates, including purines 
such as uric acid, adenine and hypoxanthine [Middel-
hoven et al., 1984],  n -alkanes or starch as sole energy and 
carbon source [Gienow et al., 1990] and nitrate as sole 
nitrogen source [Böer et al., 2009c]. Additionally, the 
yeast is thermo- and halotolerant [Wartmann et al., 1995; 
Yang et al., 2000]. It can be cultured up to 48  °  C and up to 
20% NaCl. Above 42  °  C the morphology changes from the 
yeast-budding cells to mycelia which are dependent on an 
altered gene expression pattern [Wartmann et al., 1995]. 
All of these properties support the potential of  A. adenini-
vorans as an ideal host for homo- or heterologous gene 
expression and as source for genes that have biotechno-
logical significance.
 Results 
 Isolation and Characterization of the AUOX Gene 
 The putative nucleotide sequence of the  AUOX gene 
was determined from the complete  A. adeninivorans se-
quence and annotated genome [in preparation]. It con-
tains an ORF of 921 bp with a conserved potential TATA 
element in the 5 ′ -untranslated region (78 bp upstream of 
the proposed initiation codon). The ORF encodes a pro-
tein of 306 amino acids with a molecular mass of 34.7 kDa 
and an isoelectric point of 7.02. Auoxp shows significant 
identity with other fungal urate oxidases, including  Neo-
sartorya fischeri (65%),  Neurospora crassa  (62%),  Ajello-
myces dermatitidis (61%),  Penicillium marneffei (61%), 
 Talaromyces stipitatus (61%),  Gibberella fujikuroi (61%) 
 and some Aspergillus  species (61–64%).
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 Nitrogen Source-Dependent Expression of the AOUX 
Gene 
 The regulation of  AUOX transcription was studied by 
qRT-PCR with  Arxula genes  AHBS4 ,  ALG9 ,  TEF1 and 
 TFIID as stably expressed endogenous references.  A. ade-
ninivorans LS3 cells cultured in yeast minimal medium 
(YMM)-glucose supplemented with 19 m M NH 4 H 2 PO 4 
as nitrogen source for 24 h at 30  °  C were shifted to YMM-
glucose containing 5 m M adenine, 5 m M hypoxanthine or 
5 m M NaNO 3 as nitrogen sources and monitored for 
 AUOX transcript accumulation for 24 h at 30  °  C. Imme-
diately after the shift from YMM-glucose-NH 4 H 2 PO 4 
to YMM-glucose-adenine and YMM-glucose-hypoxan-
thine, the  AUOX transcript level, calculated as transcript 
concentration in YMM-glucose-purine minus transcript 
concentration in the control YMM-glucose-NaNO 3 , in-
creased and reached a maximum at 4 h. The maximal 
transcript accumulation was 2-fold higher in yeast cells 
cultured in YMM-glucose supplemented with 5 m M hy-
poxanthine than in YMM-glucose-adenine. After 4 h the 
transcript level decreased to the basal level ( fig. 1 a).
 Urate oxidase (Auoxp) activity, produced in the same 
cultivation conditions, was determined. These investi-
gations demonstrated a strong increase of enzymatic ac-
tivity immediately after the shift from YMM-glucose-
NH 4 H 2 PO 4 to YMM-glucose-purine whereas the nega-
tive control (YMM-glucose-NH 4 H 2 PO 4 ) showed no 
increase in Auoxp. The maximal Auoxp activity was 
achieved 8 h after the shift to the uric acid medium and 
after 12 h for the adenine and hypoxanthine media, after 
which it decreased to the basal level over the next 36 h 
( fig. 1 b).
 In parallel,  AUOX transcript accumulation relative to 
purine concentration in YMM-glucose was assessed.  A. 
adeninivorans LS3 cells were harvested 2 h after a shift to 
YMM-glucose supplemented with 0.5, 1, 3, 4 and 5 m M 
uric acid, hypoxanthine or adenine or NaNO 3 as a con-
trol. The highest  AUOX transcript accumulation was 
achieved in presence of 5 m M uric acid. Lower inducer 
concentrations (0.5 and 1 m M ) resulted in lower  AUOX 
transcript levels. Furthermore, inducer concentrations 
>3 m M caused an increased accumulation of mRNA in 
the cells ( fig. 1 c).
 Urate oxidase activity was also analyzed. The enzyme 
activity was too low for analysis at 2 h after the shift to 
YMM-glucose with varying uric acid, hypoxanthine and 
adenine concentrations and consequently the yeast cells 
were harvested at 4 h. Under these conditions the urate 
oxidase activity increased up to 1 m M purine and stayed 
relatively constant to 5 m M for each inducer. In contrast, 
cells cultured in YMM-glucose-NH 4 H 2 PO 4 showed only 
weak urate oxidase activity which was independent of the 
NH 4 H 2 PO 4 concentration ( fig. 1 d).
 Production of Recombinant Urate Oxidase, Auoxp 
 The Xplor ® 2 platform has been established as a rou-
tine transformation/expression platform in  A. adeninivo-
rans [Böer et al., 2009b]. The system, which allows con-
struction of resistance marker-free yeast transformants, 
is based on a bacterial vector backbone into which yeast 
modules for selection and expression can be inserted be-
tween two 25S rDNA fragments that are arranged in the 
same orientation but in reverse order relative to the ge-
nomic rDNA. To use the Xplor ® 2 platform for construc-
tion of transgenic Auoxp strains, the ATRP1m selection 
marker module with one or two expression modules for 
Auoxp and either with or without N- or C-terminal fused 
HisTag, were inserted into the Xplor2 vector between the 
25S rDNA fragments. Yeast rDNA integrative expression 
cassettes (YRCs) were produced by digestion with  Asc I 
and yeast integrative expression cassettes (YICs) were 
produced by digestion with  Sbf I.
 Both types of linear cassette ( fig. 2 ) were successfully 
transformed into  A. adeninivorans G1212 and between 
100 and 200 transformants were obtained per microgram 
of transforming cassette. The resulting transgenic YRC/
YIC  A. adeninivorans strains carried one or two AUOX 
expression modules with constitutive  TEF1 or inducible 
 AYNI1 promoters in front of the  AUOX gene and with or 
without the 5 ′ - or 3 ′ -fused HisTag coding region (data 
not shown). After stabilization of the transgenic yeast 
strains by passaging on a non-selective medium for 30 
days (as described in the Materials and Methods section), 
there was no loss of transgenic strains during the cultiva-
tion.
 Cells for initial analysis of recombinant Auoxp accu-
mulation were grown in YMM-glucose-NaNO 3 at 30   °  C 
for 24 h. It was expected that because Auoxp does not 
contain an obvious secretion sequence, the recombinant 
protein would be localized intracellularly. Protein ex-
tracts (from approx. 50 transformants per construct) 
were consequently analyzed for the presence of recombi-
nant Auoxp activity (data not shown).
 Transgenic yeast strains with the highest recombinant 
Auoxp activities per integration cassette were then ana-
lyzed in time-course experiments. The strains listed in 
 table 1 were cultured in YMM-glucose-NaNO 3 for 96 h at 
30  °  C. This medium allows high-level expression from the 
 TEF1 and  AYNI1 promoters with cultures entering the 
stationary growth phase after approximately 24 h. Cell 
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extracts and aliquots of the culture medium were then 
analyzed for urate oxidase activity.
 In contrast to the negative control strains (activity ap-
prox. 5 U/l culture), all transformants with AUOX ex-
pression modules exhibited an intracellularly localized 
urate oxidase. Most cells achieved maximum Auoxp lev-
els within approximately 24 h (between 55 and 81 U/l 
culture), before declining to a basal level at 96 h. Maxi-
mum activity (70–90 U/l culture) was achieved in A. 
 adeninivorans strains G1212/YIC102-AYNI1-AUOX, 
G1212/YRC102-AYNI1-AUOX, G1212/YIC102-TEF1-
AUOX-6H and G1212/YRC102-TEF1-AUOX-6H 
(24 h). During 96 h of cultivation, the urate oxidase activ-
ity in YRC/YIC transformants with integrated AYNI1-
AUOX expression module decreased slightly. Only the 
YRC/YIC transformants with TEF1-AUOX-6H expres-
sion module exhibited increased urate oxidase levels at 
the end of the 96-hour cultivation. A correlation between 
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 Fig. 1. Influence of the nitrogen source on  AUOX transcript accu-
mulation ( a ,  c ) and urate oxidase activity ( b ,  d ).  A. adeninivorans 
LS3 was cultured for 24 h at 30  °  C in YMM-glucose supplemented 
with 19 m M NH 4 H 2 PO 4 and then shifted to YMM-glucose supple-
mented with different nitrogen sources in different concentrations 
and cultured for a further 24 h. The  AUOX transcript was analyzed 
by qRT-PCR with the  Arxula genes,  AHBS4 ,  ALG9 ,  TEF1 and
 TFIID used as stable expressed endogenous references ( a ) and
48 h for the detection of the urate oxidase activities ( b ). The yeast 
cells were shifted in YMM-glucose supplemented with ( a ) 5 m M 
adenine, hypoxanthine and NaNO 3 , ( b ) 5 m M adenine, hypoxan-
thine, uric acid and NH 4 H 2 PO 4 , ( c ) 0.5, 1, 3, 4 and 5 m M adenine, 
hypoxanthine or NaNO 3 for 2 h, ( d ) 0.25, 0.5, 1, 2.5 and 5 m M ad-
enine, hypoxanthine, uric acid or NH 4 H 2 PO 4 for 4 h. Normalized 
relative quantities are calculated using the model of Hellemans et 
al. [2007] by adjusting for differences in PCR efficiency between 
the gene of interest and multiple reference genes. 
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the activity levels of YRC and YIC transformants or the 
number of AUOX expression modules was not detect-
able; however, the maximum yield coefficients (Y[P/X]) 
measured in G1212 strains with TEF1-AUOX-6H ex-
pression modules were up to 30% higher than in the 
transformants containing the TEF1-AUOX or TEF1-6H-
AUOX expression modules ( table 1 ;  fig. 3 ).
 Parameters of Urate Oxidase 
 The endogenous urate oxidase was purified to homo-
geneity by fractionated ammonium sulfate precipitation, 
followed by DEAE-Sepharose ion exchange chromatog-
raphy and gel filtration on a Superdex TM 200 column, as 
described in the Materials and Methods section. The final 
yield and specific activity were 1% and 0.65 U/mg protein, 
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 Fig. 2. Physical maps of yeast integration-
expression cassettes (YRC and YIC) used 
in this study. The selection module con-
tains the selection marker  ATRP1m fused 
to the  ALEU2 promoter. The selection 
module is fused to none ( a ), one ( b ,  c ,  e ,  f ) 
or two expression modules ( d ). The expres-
sion modules contain the following ele-
ments:  A. adeninivorans -derived  consti-
tutive  TEF1 ( c–f ) or inducible  AYNI1 
( b ) promoter,  AUOX -coding sequence 
 (AUOX) ( b–f ) and  S. cerevisiae -derived 
 PHO5 terminator ( b–f ).  AUOX -coding se-
quences are fused to C-terminal HisTag ( e ) 
or N-terminal HisTag ( f ) encoding se-
quences. YRCs ( Asc I fragments) are flanked 
by 25S rDNA sequences for targeting. YICs 
without 25S rDNA targeting sequences 
were obtained as  Sbf I fragments. 
Table 1.  Maximum yields of urate oxidase activity obtained in recombinant strains of A. adeninivorans
Yeast strain Auoxp activity, U/l culture Dry cell weight, g dcw/l culture Yield coefficient (P/X),  U/g dcw
24 h 96 h 24 h 96 h  24 h 96 h
G1212/YIC102 5.3 5.5 3.8 4.4 1.4 1.2
G1212/YIC102-AYNI1-AUOX 81.3 68.3 3.3 4.7 25.2 14.5
G1212/YIC102-TEF1-AUOX 76.8 44.6 3.8 4.6 20.6 9.6
G1212/YIC102-TEF1-2AUOX 58.7 35.0 3.9 4.9 15.0 7.2
G1212/YIC102-TEF1-AUOX-6H 70.3 86.2 3.9 5.1 18.4 16.9
G1212/YIC102-TEF1-6H-AUOX 66.9 51.0 3.4 4.8 19.5 10.8
G1212/YRC102 5.4 4.8 3.7 4.7 1.5 1.0
G1212/YRC102-AYNI1-AUOX 81.1 81.5 3.2 4.6 26.0 17.6
G1212/YRC102-TEF1-AUOX 54.9 31.0 3.7 4.8 14.8 6.6
G1212/YRC102-TEF1-2AUOX 76.2 31.5 3.9 4.5 19.7 7.1
G1212/YRC102-TEF1-AUOX-6H 80.3 84.5 4.0 4.9 20.0 17.2
G1212/YRC102-TEF1-6H-AUOX 61.0 35.3 4.0 4.9 15.5 7.2
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respectively. A protein band with an apparent molecular 
mass of 35 kDa was detected by SDS-PAGE ( fig. 4 a). This 
band was cut out and the protein was digested with the 
endopeptidase trypsin. The resulting peptides were ana-
lyzed by MALDI-TOF and ESI-Q-TOF mass spectrom-
etry, which revealed an amino acid overlay of 37% with 
the putative amino acid sequence of the  A. adeninivorans 
urate oxidase Auoxp (data not shown).
 In parallel, the recombinant Auox6hp was isolated and 
purified from  A. adeninivorans G1212/YRC102-TEF1-
AUOX-6H by Ni-NTA His Bind Resin column chro-
matography ( fig. 4 b) and by the method used for the en-
dogenous urate oxidase. The endogenous Auoxp and
recombinant urate oxidases Auox6hp exhibited similar 
characteristics. Both enzymes were shown to have a mo-
lecular mass of approximately 67 kDa by analytical gel 
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 Fig. 3. Time courses of expression of urate 
oxidase by transgenic strains of  A. adenini-
vorans . Transformants G1212/YIC102-
AYNI1-AUOX ( a ), G1212/YIC102-TEF1-
AUOX-6H ( b ), G1212/YRC102-AYNI1-
AUOX ( c ) and G1212/YRC102-TEF1-
AUOX-6H ( d ) were cultured in shake 
flasks for 96 h at 30   °   C in the presence of 
YMM-glucose-NaNO 3 . At the indicated 
time, 2-ml aliquots of the culture were as-
sayed for intracellular urate oxidase activ-
ity (activity in U/l, triangle) and to deter-
mine biomass (dcw in g/l, asterisk) as de-
scribed in the Materials and Methods 
section, and to calculate the urate oxidase 
output (Y(P/X) in U/g dcw, square).
 Fig. 4. SDS-PAGE analysis of purified en-
dogenous Auoxp ( a ) and recombinant 
Auox6hp ( b ) from  A. adeninivorans LS3 
and G1212/YRC102-TEF1-AUOX-6H.
 a  A. adeninivorans LS3 cells were cultured 
for 24 h at 30   °   C in YMM-glucose-NaNO 3 
and then shifted to 5 m M YMM-glucose-
adenine for 6 h. After harvesting and dis-
rupting the yeast cells, the crude extract (1) 
was purified by fractionated ammonium 
sulfate precipitation (2), DEAE ion ex-
change chromatography (3), Superdex TM 
200 chromatography (4) and then electro-
phoresed on 12% SDS-PAGE.  b  A. adeni-
nivorans G1212/YRC102-TEF1-AUOX-
6H cells were cultured for 24 h at 30   °   C
in YMM-glucose-NaNO 3 , harvested, crude 
extracts prepared (1, 10) and purified by 
Ni-NTA chromatography. The following 
purification steps flow-through 1st (2, 11), 
flow-through 2nd (3, 12), washing with
5 m M imidazole (4, 13), washing with 100 
m M imidazole (5, 14), eluate 1 (6, 15), elu-
ate 2 (7, 16), eluate 3 (8, 17), eluate 4 (9, 18) 
(all eluation steps with 1 ml 1  M imidazole) 
were electrophoresed on 12% SDS-PA gels 
(1–9) and analyzed by immunoblot analy-
sis with anti HisTag antibodies (10–18). 
 3 
 4 
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filtration, while forming a distinct band at approximately 
35 kDa on denaturing SDS-PA gels. These data indicate 
that the active enzyme is probably a homodimer.
 Enzymatic Analysis of Endogenous and Recombinant 
Urate Oxidase 
 Both urate oxidases exhibit similar biochemical pa-
rameters with pH and temperature optima of 8.0 and 
40  °  C for the endogenous Auoxp and 9.5 and 35  °  C for the 
recombinant Auox6hp with C-terminal HisTag. Both 
proteins had similar urate oxidase activity over a broad 
temperature and pH range (Auoxp 25–40  °  C, pH 7.5–9.5; 
Auox6hp 30–45   °   C, pH 8.0–10.0). The residual enzyme 
activity after incubation for 2 h at 37   °  C was constant at 
pH 7.5–9.5 (Auoxp) and at pH 8.0–10.0 (Auox6hp). In 
addition, both urate oxidases have high thermostabilities 
with incubations for 1 h at 50  °  C reducing the residual ac-
tivity of both enzymes by less than 10%. The K m value of 
the purified urate oxidase was determined by Hanes-
Woolf plot and was approximately 56 μ M for the endog-
enous and 71 μ M for the recombinant urate oxidase ( ta-
ble 2 ).
 Various metal ions and reagents were assayed for their 
effects on urate oxidase activity. The enzyme was com-
pletely inactivated in the presence of 1.0 m M Cu 2+ and 
Hg 2+ . The residual activity in the presence of 1 m M Zn 2+ , 
Co 2+ and Ni 2+ was less than 25% and in the presence of
1 m M Ca 2+ the residual activity was 50%, whereas Fe 3+ , 
Mg 2+ , Na + , NH 4 + , EDTA, 1,10-phenanthroline and phe-
nyl methyl sulfonyl fluoride (PMSF) had weak or no effect 
on the endogenous urate oxidase and only weak activat-
ing effects on the recombinant Auox6hp, whereas dithio-
threitol and  L -cysteine increased the enzymatic activity 
( table 3 ).
 The substrate specificity of the enzyme was deter-
mined using a variety of uric acid analogues and purine 
derivates. Only uric acid was converted to H 2 O 2 and al-
lantoin which was determined using (A) the H 2 O 2 quan-
tification method and (B) absorbance spectra differences 
between of 230 and 330 nm during incubation for 1 h at 
37   °   C (data not shown). The addition of uric acid ana-
logues, 8-azaxanthine and oxonic acid, caused a decrease 
of enzymatic activity to less than 25%. All other analogues 
or purine derivates that were tested exhibited only weak 
effects or had no effect ( table 4 ).
 Use of Urate Oxidase to Reduce Uric Acid in Beef 
Stock 
 Investigation of the application of urate oxidase 
Auox6hp for the reduction of uric acid in food was done 
Table 2.  Properties of the endogenous and recombinant urate oxi-
dases synthesized in A. adeninivorans LS3 and G1212/YRC102-
TEF1-AUOX-6H
Property Endogenous 
urate oxidase
Recombinant 
urate oxidase
pH optimum* 8.0 9.5
pH stability* 7.5 – 9.5 8.0 – 10.0
Temperature optimum*, °C 40 35
Temperature stability, °C up to 50 up to 50
Michaelis-Menten constant (Km), μm 56 71
kcat, 1/s 38 121
kcat/Km, 1/μm s 0.68 1.71
Mr native, Da 70,000 70,000
Mr denatured, Da 34,700 35,500
 The Michaelis constant was estimated using Hanes-Woolf plot. 
pH stability was defined as the range and thermal stability as high-
est temperature at which over 80% of the initial activity was re-
tained after incubation time of at least 60 min.
* Addition of 2 mM DTT (final concentration).
Table 3.  Effects of various cations and inhibitors on the stability 
and activity of the endogenous and recombinant urate oxidase
Compound Concen-
tration, 
mm
Endoge-
nous urate 
oxidase, %
Recombi-
nant urate 
oxidase, %
Control (without compound) – 100 100
CaCl2* 1/0.1 67/101 56/112
CoCl2* 1/0.1 18/123 4/134
CuCl2* 1/0.1 9/8 0/4
CuSO4* 1/0.1 5/8 0/3
FeCl3* 1/0.1 85/85 109/112
MgCl2* 1/0.1 90/95 119/129
NaCl* 1/0.1 94/99 127/108
NiCl2* 1/0.1 29/97 24/121
NiSO4* 1/0.1 28/100 26/109
NH4Cl* 1/0.1 95/98 123/104
ZnCl* 1/0.1 25/108 47/114
ZnSO4* 1/0.1 20/103 24/107
EDTA 1/0.1 112/110 110/106
HgCl2 1/0.1 0/11 4/7
1,10-Phenanthroline 1/0.1 86/103 87/99
DTT 1/0.1 151/150 127/126
l-Cysteine 1/0.1 144/151 119/129
PMSF 1/0.1 103/104 112/107
 The enzyme was incubated for 1 h at 37° C in potassium phos-
phate buffer pH 7.7 containing the indicated concentrations of 
listed supplements. The residual activity was measured with stan-
dard enzyme assay (UV measurement) as described in the Mate-
rial and Methods section. * Contained 2 mm l-cysteine.
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with beef stock (50 mg/ml REWE Bio Rinderbrühe; 
REWE, Germany). It contains 0.2 mg/l uric acid, 1.8 mg/l 
xanthine, 3.4 mg/l adenine, 13.4 mg/l hypoxanthine and 
35.2 mg/l guanine. Only allantoin was not detectable with 
the HPLC system. However, the uric acid content of this 
product is relatively low and it was supplemented with 
additional uric acid to provide a realistic investigation. 
After incubation for 60 min at 40  °  C with 0.2 U/ml urate 
oxidase, the beef stock was analyzed for uric acid by 
HPLC. The control, beef stock with 0.2 U/ml urate oxi-
dase, without incubation, contained 28.7 mg/l uric acid. 
In contrast, the concentration in the sample incubated 
with urate oxidase at 40  °  C for 60 min was 0.3 mg/l ( fig. 5 ).
 Discussion 
 Hyperuricemia, and its symptoms, gout, tophi and 
acute uric acid nephropathy, is widespread in industrial 
countries (1–2% of adults) [Sorbera et al., 2010]. Reduced 
renal uric acid excretion and increased uric acid synthesis 
result in increased serum uric acid concentrations. Non-
steroidal anti-inflammatory drugs are commonly used to 
treat the symptoms and xanthine oxidase inhibitors and 
uricosuric agents are given as prophylactic therapies 
[Burns and Wortmann, 2011; Wittköpper et al., 2011]. 
Additionally, avoiding purine-rich food, reduction of al-
cohol intake and a reduction of weight is essential for suc-
cessful control of the condition [Wolfram, 1992]. We of-
fer a new approach which involves the reduction of urate 
in food by treatment with urate oxidase from  A. adenini-
vorans LS3 either before or during the meal and the diges-
tion process.
 The genome data from  A. adeninivorans LS3 was used 
to identify the  AUOX gene, a 921-bp ORF. The  AUOX 
gene is a single copy gene as described for most organisms 
Table 4.  Effects of purine derivates on the endogenous and recom-
binant urate oxidase activity
Purine Endoge-
nous urate 
oxidase
activity, %
Recombi-
nant urate 
oxidase 
activity, %
Control (without additional purine) 100 100
Adenine 111 108
Adenosine 105 103
Allantoin 102 99
8-Azaxanthine 22 26
Caffeine 102 92
Guanosine 111 100
Hypoxanthine 116 104
Inosine 106 100
Oxonic acid potassium salt 9 18
Theobromine 113 100
Xanthine 82 66
Xanthosine 103 98
 The enzyme reaction was performed under standard condi-
tions (H2O2 measurement), except that the purine derivates were 
added additionally in the same concentration as uric acid to the 
reaction buffer. The residual activity was measured as described in 
the Materials and Methods section.
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 Fig. 5. HPLC analysis: 0.5 mg/ml stock so-
lutions of the purine standards were used 
for determination of their retention times 
(dashed line) with adenine (1), hypoxan-
thine (2), xanthine (3), guanine (4a, b) and 
uric acid (5). The profile of the beef stock 
solution with additional uric acid and 0.2 
U/ml recombinant urate oxidase Auox6hp 
without incubation time (thick line) and 
after 60 min at 40  °  C (thin line). 
 Trautwein-Schult et al.
 
 J Mol Microbiol Biotechnol 2013;23:418–430 
DOI: 10.1159/000353847
426
[Oda et al., 2002]. Transgenic  A. adeninivorans producer 
strains were constructed that accumulated high levels of 
recombinant urate oxidase. The Xplor ® 2 transforma-
tion/expression platform [Böer et al., 2009b], previously 
used to transform  A. adeninivorans and other yeasts to 
synthesize biotechnologically interesting enzymes such 
as Alip1p [Böer et al., 2005], Atan1p [Böer et al., 2009a] 
and RR-ADH [Giersberg et al., 2012], was used to express 
the  AUOX gene in  A. adeninivorans . The  AUOX gene was 
integrated into the genome of the yeast as described in 
Böer et al. [2009b, 2011].
 A. adeninivorans YIC and YRC strains with one or two 
expression modules containing the  AUOX gene, with and 
without 3 ′ - or 5 ′ -fused HisTag encoding region, were 
compared for accumulation of recombinant Auoxp. 
YRC/YIC strains with inducible  AYNI1 promoter 
achieved the highest productivity (G1212/YIC102-
AYNI1-AUOX – 25.2 U/g dcw; G1212/YRC102-AYNI1-
AUOX – 26.0 U/g dcw) at the end of the exponential 
growth phase (24 h). However, using the constitutive 
 TEF1 promoter and the  AUOX gene flanked by HisTag 
encoding sequences at the 3 ′ -end achieved 18.4 U/g dcw 
(G1212/YIC102-TEF1-AUOX-6H) and 20.0 U/g dcw 
(G1212/YRC102-TEF1-AUOX-6H) at end of the expo-
nential growth phase (24 h). The results show an increase 
in Auoxp stability with C-terminal HisTag fusions com-
pared with an N-terminal HisTag and Auoxp without 
HisTag. In contrast, only small differences were detected 
in the maximal yield coefficients between transgenic yeast 
strains with one or two AUOX expression modules inte-
grated into the genome. This is similar to the transgenic 
 A. adeninivorans RR-ADH producers in which an in-
creased number of expression modules resulted in most 
transgenic strains with two or more expression modules 
showing no increase in yield, although two transgenic 
strains did produce higher yield coefficients [Giersberg et 
al., 2012]. In contrast, recombinant tannase producers 
with two expression modules exhibited reduced maximal 
yield coefficient [Böer et al., 2011]. Cultivation in fed-
batch fermentation mode may enhance the production
of Auoxp by transgenic  A. adeninivorans strains as was 
demonstrated for tannase [Böer et al., 2011].
 The regulation of the purine degradation pathway has 
been described for  Aspergillus nidulans [Scazzocchio and 
Darlington, 1968] and  Candida sp. [Liu et al., 1994] using 
enzyme activity assays. They found that directly after the 
addition of purines, such as adenine and uric acid, the 
respective genes are activated. This situation was con-
firmed in the purine degradation experiments in  A. ade-
ninivorans LS3. The  AUOX transcript accumulation 
reached a maximum level at 4 h, whereas an increase 
Auoxp activity level was delayed 4–8 h. The reasons for 
this effect could be higher stability of Auoxp compared 
to the  AUOX transcripts, which prevents intracellular 
uric acid accumulation during the degradation of ade-
nine and other purines. The induction of  AUOX tran-
script accumulation or Auoxp activity was dependent of 
the inducer concentration. This effect was not described 
in further works.
 The 67-kDa Auoxp comprises two subunits with mo-
lecular sizes of about 35 kDa. Known urate oxidase sub-
units range from 30 to 80 kDa. Different enzyme struc-
tures have been described: monomer [Liu et al., 1994], 
dimer [Lucas et al., 1983], homotetramer [Giffard et al., 
2011; Nishimura et al., 1982] and heterotetramer [Bon-
gaerts et al., 1978].
 Partially purified endogenous Auoxp showed opti-
mum activity at pH 8.0 and 40   °   C which are properties 
shared with urate oxidases from  Aspergillus flavus [Li et 
al., 2006],  Bacillus subtilis [Pfrimer et al., 2010] and  Can-
dida utilis [Liu et al., 2011]. However, Auox6hp showed 
an increase in pH optimum to pH 9.5. The K m values in-
dicate a high affinity of urate oxidase for uric acid as sub-
strate and are comparable with  C. utilis (33.7 μ M ) and 
 Bacillus fastidiosus (180 μ M ) [Bongaerts et al., 1978; Liu et 
al., 2011]. The reason for differences in pH, temperature 
profiles and kinetic parameters of Auox6hp may be 
caused by the C-terminal HisTag which can have influ-
ence on the protein structure and protein charge [Votchit-
seva et al., 2006]. The enzymatic activity of both recom-
binant and endogenous urate oxidase was stable up to 
50  °  C for at least 1 h. This physicochemical property will 
be useful in using urate oxidase to treat heated food prod-
ucts.
 Auoxp was inactivated in presence of Cu 2+ or Hg 2+ 
which was also observed in the urate oxidases of  Micro-
bacterium sp.,  C. utilis and  Arthrobacter globiformis [Kai 
et al., 2008; Nishimura et al., 1982; Suzuki et al., 2004]. 
This effect was not however detected in  B. fastidiosus 
[Bongaerts et al., 1978]. The increase in enzymatic activ-
ity seen with dithiothreitol and  L -cysteine has also been 
reported for  C. utilis urate oxidase [Nishimura et al., 
1982]. These results suggest that sulfhydryl groups could 
be located close to the active site of the enzyme or be of 
significance in conformation of the protein structure.
 Recombinant Auoxp, synthesized in C-terminal fu-
sion with HisTag as Auox6hp in transgenic  A. adeninivo-
rans strains, was used to reduce uric acid concentration 
in a food product and demonstrates the potential of the 
enzyme as part of a new strategy to prevent hyperurice-
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mia. The strategy will require enzymes that degrade pu-
rines and purine derivatives such as hypoxanthine to be 
commercially available to ensure complete removal of the 
molecules that cause hyperuricemia.
 Materials and Methods 
 Strains, Media and Cultivation 
 Escherichia coli XL1-Blue ( recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac  [ F ′ proAB lacI q Z Δ M15  Tn 10 (Tet r )]) obtained 
from Stratagene (La Jolla, Calif., USA), served as the host strain for 
bacterial transformation and plasmid isolation. The strain was 
grown on LB medium supplemented with ampicillin (100 μg/ml) 
or kanamycin (50 μg/ml) for selection.
 The yeast wild-type strain  A. adeninivorans LS3, isolated from 
wood hydrolysates in Siberia (Russia) [Gienow et al., 1990] and 
deposited as  A. adeninivorans SBUG 724 in the strain collection of 
the Department of Biology of the University of Greifswald, and the 
auxotrophic mutant  A. adeninivorans G1212 [ aleu2 atrp1::ALEU2 ] 
[Steinborn et al., 2007], were used in this study. All yeast strains 
were grown up to 96 h at 30   °   C under non-selective conditions in 
a yeast-extract-peptone-medium (YEPD) or under selective con-
ditions in a YMM supplemented with 1% (w/v) glucose (YMM-
glucose) containing different nitrogen sources at various concen-
trations [Tanaka et al., 1967].
 Agar plates were prepared by addition 1.6% (w/v) agar to the 
liquid media.
 Isolation of the AUOX Gene and Construction of Auoxp 
Expression Plasmids 
 The potential  Arxula urate oxidase  (AUOX) gene was identified 
from the complete sequenced and annotated genome data of  A. 
adeninivorans LS3 [in preparation] and the  AUOX nucleotide se-
quence has been submitted to the GenBank/EMBL data libraries 
(HF558665).
 To express the  AUOX gene in  A. adeninivorans G1212, the ORF 
was amplified by PCR from chromosomal DNA of  A. adeninivo-
rans LS3, using primers that incorporated flanking  Eco RI and  Not I 
restriction sites (AUOX5/AUOX3;  table 5 ). The amplified  Eco RI-
 AUOX - Not I gene fragment, which corresponds to the complete 
ORF, was inserted into the plasmids pBS-TEF1-PHO5-SS and 
pBS-AYNI1-PHO5-SS (both flanked by  Spe I and  Sac II) between 
the  A. adeninivorans -derived constitutive  TEF1 or inducible 
 AYNI1 promoter and the  S. cerevisiae -derived  PHO5 terminator 
[Arima et al., 1983; Böer et al., 2009c].
 Plasmids were constructed with single AUOX expression mod-
ules, the  TEF1 promoter –  AUOX gene –  PHO5 terminator and 
 AYNI1 promoter –  AUOX gene –  PHO5 terminator fragments. 
These fragments were flanked by  Spe I and  Sac II restriction sites and 
were inserted into the plasmid Xplor2.2 [Böer et al., 2009b] to gen-
erate the  Arxula plasmids Xplor2.2-TEF1-AUOX and Xplor2.2-
AYNI1-AUOX. Here the selection marker module ( ALEU2  promot-
Table 5.  PCR and qRT-PCR primers used in the construction of the plasmids pBS-AYNI1-AUOX-PHO5-SS, pBS-TEF1-AUOX-PHO5-
SS, pBS-TEF1-6H-AUOX-PHO5-SS, pBS-TEF1-AUOX-6H-PHO5-SS and Xplor2.2-TEF1-2AUOX and in the calculation of AUOX 
transcript accumulation in A. adeninivorans LS3
Name Nucleotide sequence Position in gene
sequence or plasmid
AUOX5 5′-ATGTAGAATTCATGTCCCATCTCTCTGCTGC-3′ 1 – 20
AUOX3 5′-AATGCGGCCGCTTAGAGCTTAGCAGTGTTACGGGTGACAG-3′ 921 – 892
AUOX5-His 5′-ATTTGGAATTCATGCATCATCACCATCACCATTCCCATCTCTCTGCTGCCCGTTACGG-3′ 1 – 47
AUOX3-His 5′-TTCACGCGGCCGCTTAATGGTGATGGTGATGATGGAGCTTAGCAGT-3′ 939 – 892
TEF1-SpeI 5′-GTCGAGACTAGTCTCGACTTCAATCTATAATC-3′ 899 – 918
[pBS-TEF1-AUOX-
PHO5-SS]
PHO5-SpeI 5′-TTATTACTAGTCGGCCCCAGCTTGCATGCCTG-3′ 2306 – 2286
[pBS-TEF1-AUOX-
PHO5-SS] 
AUOX-fw-rtPCR 5′-GAACACTGGCAAGAACGC-3′ 828 – 845
AUOX-rv-rtPCR 5′-CTTAGAGCTTAGCAGTGTTACG-3′ 922 – 901
AHSB4-fw-rtPCR 5′-CTCATTTATGAGGAGACCCG-3′ 200 – 219
AHSB4-rv-rtPCR 5′-ATAAAGAGTTCGTCCCTGTC-3′ 349 – 330
ALG9-fw-rtPCR 5′-CATGGGCCAAGGTATACTG-3′ 1502 – 1520
ALG9-rv-rtPCR 5′-AGAATGCGACCGATACCA-3′ 1568 – 1551
TEF1-fw-rtPCR 5′-CTCTTGGACGATTCGCC-3′ 1253 – 1269
TEF1-rv-rtPCR 5′-CCGTTACCGACAATCTATTT-3′ 1398 – 1379
TFIID-fw-rtPCR 5′-AGTTTGTGTCTGATATTGCCTC-3′ 500 – 521
TFIID-rv-rtPCR 5′-GAAGAGCTTGCTACCGAACT-3′ 575 – 556
EcoRI (GAATTC), NotI (GCGGCCGC) and SpeI (ACTAGT) restriction sites are underlined, the sequences corresponding to the ORF are given in bold 
type. The nucleotide position is given relative to the first nucleotide of the respective ORF.
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er- ATRP1m,  and  Eco 47III,  Spe I,  Sac II,  Sal I,  Apa I multicloning re-
striction sites for insertion) is flanked by 25S rDNA target sequences.
 Xplor2.2-TEF1-2AUOX, which carries two AUOX expression 
modules in same orientation, was obtained by inserting the  TEF1 
promoter –  AUOX gene –  PHO5 terminator module flanked by 
 Spe I restriction sites into Xplor2.2-TEF1-AUOX. The  TEF1 pro-
moter –  AUOX gene –  PHO5 terminator expression module was 
amplified by PCR from the  TEF1 promoter –  AUOX gene –  PHO5 
terminator fragment of plasmid pBS-TEF1-AUOX-PHO5-SS, us-
ing primers that incorporated the flanking  Spe I cleavage sites 
(TEF1-SpeI/PHO5-SpeI;  table 5 ).
 In addition, a 6 × HisTag coding sequence was inserted at the 
3 ′ -end and at the 5 ′ -end (behind the ATG) of the  AUOX ORF us-
ing PCR. The complete gene construct, including the flanking re-
striction sites, was amplified by PCR from chromosomal DNA
of  A. adeninivorans LS3 using primer combinations AUOX5/
AUOX3-His or AUOX5-His/AUOX3 ( table 5 ) to construct genes 
 AUOX - 6H and  6H - AUOX , respectively.
 The amplified  Eco RI- Not I  AUOX - 6H and  6H - AUOX ORFs 
were inserted into  plasmid pBS-TEF1-PHO5-SS as described be-
fore. Both of the resulting 6H-AUOX and AUOX-6H expression 
modules flanked by  Spe I- Sac II restriction sites were inserted into 
Xplor2.2 to generate Xplor2.2-TEF1-AUOX-6H and Xplor2.2-
TEF1-6H-AUOX.
 All plasmids were digested with  Asc I or  Sbf I to remove all  E. coli 
sequences prior to transformation. In the resulting cassettes, the 
module combination was flanked (YRCs) or not (YICs) by the two 
25S rDNA fragments. All YRCs and YICs were introduced in lin-
ear form ( fig. 2 ) into  A. adeninivorans G1212.
 Transformation Procedures, Isolation and Characterization of 
Nucleic Acids 
 Transformation of  E. coli XL1-Blue competent cells from Strat-
agene followed the procedure described by Inoue et al. [1990].  A. 
adeninivorans transformants were generated according to Rösel 
and Kunze [1998]. Stable yeast transformants were obtained by a 
method described by Klabunde et al. [2003] after a sequence of 
passages on selective (YMM-glucose) and non-selective (YEPD) 
media. Isolation of plasmid DNA and restriction fragments was 
carried out as previously described [Wartmann et al., 2002].
 For RNA isolation, yeast cells were suspended in lysis buffer
(8  M guanidine hydrochloride, 20 m M MES, 20 m M EDTA, 1.25% 
(v/v) β-mercaptoethanol, pH 7.0). The isolation of total RNA was 
carried out according to Logemann et al. [1987]. To obtain DNA-
free RNA, a DNase I (Fermentas, St. Leon-Rot, Germany) diges-
tion step, as described in the manufacturer’s instructions was in-
cluded. cDNA was synthesized following the recommendations 
provided in the instruction manual ‘ Revert AidH Minus – First 
Strand cDNA Synthesis’ (Fermentas). In order to quantify the 
 AUOX transcript accumulation by qRT-PCR, appropriate frag-
ments were amplified by PCR from cDNA using the oligonucle-
otide primers listed in  table  5 . The relative expression level of 
 AUOX mRNA was calculated as described by Hellemans et al. 
[2007] and Pfaffl [2001]. The  Arxula genes  AHBS4 ,  ALG9 ,  TEF1 
and  TFIID were used as endogenous references ( table 5 ).
 Urate Oxidase Assays and Protein Analysis 
 Yeast cells were harvested (5,000  g , 4  °  C for 5 min), washed and 
suspended in 500 μl 0.1  M potassium phosphate buffer pH 8.0 and 
500 μl silica beads (0.5 mm; BioSpec Products, Bartlesville, Okla., 
USA). The mixture was shaken 3 min at 30 Hz in Mill MM 400 
mixer (Retsch, Haan, Germany), glass beads and cell material sep-
arated (11,000  g , 4   °   C, 10 min) and the supernatant used for the 
analyses.
 Urate oxidase activity was assayed by quantification of (A) uric 
acid and (B) H 2 O 2 . For quantification A, the enzyme activity was 
determined spectrophotometrically by monitoring the decrease of 
absorbance at 293 nm using an extinction coefficient of 12.2 × 10 3 
l/mol cm [Kalckar, 1947]. Standard assay mixtures, containing the 
sample, 0.1  M potassium phosphate buffer pH 8.0 and 0.2 m M uric 
acid, were incubated at 37  °  C. One unit of urate oxidase activity was 
defined as the ability to catalyze the transformation of 1 μmol uric 
acid to allantoin per minute at 37  °  C and pH 8.0.
 For H 2 O 2 quantification B, the urate oxidase activity was as-
sayed by formation of red chromogen, which is produced by reac-
tion of H 2 O 2 with phenol, 4-aminoantipyrine and peroxidase as 
described by Lotfy [2008]. One unit of urate oxidase activity was 
defined as the amount of enzyme required to produce 1 μmol H 2 O 2 
per minute at 37  °  C and pH 8.0. Urate oxidase levels were expressed 
as U/mg protein or as U/l culture.
 For the isolation and purification of the urate oxidase,  A. ade-
ninivorans cells were grown in YMM-glucose supplemented with 
5 m M adenine (wild-type LS3) or 43.5 m M NaNO 3 (transformant) 
as nitrogen source. Cells were harvested, suspended in 0.1  M potas-
sium phosphate buffer pH 8.0 and disrupted using a Mill MM 400 
mixer (Retsch) with glass beads at 30 Hz. The proteins of the cell 
extract were fractionally precipitated using 35 and 65% ammoni-
um sulfate (final concentration), centrifuged (4,000  g , 4   °   C, 15 
min), dissolved in 0.1  M potassium phosphate buffer pH 7.4 and 
dialyzed against 50 m M potassium phosphate buffer pH 7.4 for
12 h.
 The endogenous urate oxidase was subsequently purified to 
homogeneity by DEAE-Sepharose column chromatography and 
gel filtration on a Superdex TM 200 column [Böer et al., 2009a].
 Recombinant urate oxidase (Auox 6h p), with a HisTag, was 
purified by column chromatography on Ni-NTA His breach Bind 
Resin (Novagen, Madison, Wisc., USA) and was desalted on PD10 
desalting columns (Amersham Bioscience, Uppsala, Sweden) fol-
lowing the recommendations provided in the instruction manual.
 The molecular masses of the enzymes purified from the wild-
type and recombinant sources were estimated by gel filtration over 
Superdex TM 200. As calibration standards, dextran blue (M r 2,000 
kDa), ferritin (M r 443 kDa), catalase (M r 232 kDa), alcohol dehy-
drogenase (M r 150 kDa), BSA (M r 67 kDa) and ovalbumin (M r 42.8 
kDa) were used.
 For further analysis, the endogenous urate oxidase Auoxp and 
recombinant Auox6hp were electrophoretically separated by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) under denatur-
ing conditions [Laemmli, 1970]. Western analyses were performed 
as described by Towbin et al. [1979] and treated with anti-HisTag-
specific antibodies as described by Böer et al. [2009a]. The dye-
binding method of Bradford [1976] was used for protein quantifi-
cation using bovine serum albumin (BSA) as standard.
 Cells recovered from 1-ml samples of culture were washed 
twice in distilled water and dried until no further change in weight 
was noticed to determine the dry cell weight (dcw).
 HPLC Analysis of Urate Oxidase Substrates and Products 
 To identify urate oxidase reaction products, the following com-
pounds were tested: uric acid, guanine, xanthine and hypoxan-
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thine (Sigma-Aldrich, St. Louis, Mo., USA) and adenine (Fluka 
Analytical, St. Gallen, Switzerland). Additionally, 0.2 U/ml urate 
oxidase was mixed with beef stock (REWE Bio Rinderbrühe; 
REWE, Germany, 1 g diluted in 1.5 ml 0.5  M NaOH + 18.5 ml
0.1  M potassium phosphate buffer pH 3.0) and incubated at 40  °  C. 
The reaction was stopped by heating at 100  °  C for 5 min. After cen-
trifugation, aliquots (20 μl) of the supernatant were loaded onto an 
HPLC system (Hitachi LaChrom Elite ® L-2130; Merck, Darm-
stadt, Germany) equipped with a TSKgel Amide-80 analytical col-
umn (250 × 4.6 mm; Tosoh, Tokyo, Japan) and fractionated by 
isocratic elution at a flow rate of 1.2 ml/min. Signals were detected 
at 260 nm. The eluent was acetonitrile and 0.1% trifluoroacetic acid 
(85: 15 v/v) over a period of 20 min at 22  °  C. Purines were identified 
by comparison of their retention times with that of the pure uric 
acid, guanine, xanthine, hypoxanthine and adenine.
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